Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Uterine Neoplasms 1Obesity 1Neoplasms 1Motor Activity 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 27Dexmedetomidine 8Radiotherapy 7Radiation 7Proton Therapy 7Mental Status and Dementia Tests 7Magnetic Resonance Imaging 7Exercise 6Surgical Procedures, Operative 5Specimen Handling 5Saline Solution 5Blood Specimen Collection 5Bevacizumab 5Remifentanil 4Radiotherapy, Intensity-Modulated 4Propofol 4alovudine 3Transcranial Magnetic Stimulation 3Temozolomide 3Resistance Training 3Methods 3Mannitol 3Diffusion Tensor Imaging 3Cognitive Training 3gadobutrol 2gadobenic acid 2Yoga 2Vitamin D 2Ultrasonography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Brain Neoplasms × Neuroimaging × Clear all
NCT06247449 2025-12-18

MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

Sunnybrook Health Sciences Centre

Phase NA Recruiting
100 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡